Board to consider Dividend

Updated on: May 17, 2017

Shukra Pharmaceuticals Ltd has informed BSE that the meeting of the Board of Directors of the Company will be held on May 30, 2017, inter alia, to transact the following business: 1. To consider, adopt and approve Audited Financial Results for the quarter ended on March 31, 2017. 2. To recommend dividend for Financial Year 2016-17. Moreover Company is hereby informing that Trading Window of the Company will remain close from May 17, 2017 to June 01, 2017 both days inclusive.

Pdf Link: Board to consider Dividend

Source : BSE - www.bseindia.com

Published on February 02, 2018

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

This article is closed for comments.
Please Email the Editor

You May Also Like

Recommended for you